Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices

Dermatol Surg. 2016 May;42(5):586-97. doi: 10.1097/DSS.0000000000000754.

Abstract

Background: The aging process is a complex interplay of intrinsic and extrinsic factors across multiple layers of the face. Accordingly, combining aesthetic interventions targeting different manifestations of aging often leads to better results than single modalities alone. However, no guidelines for a pan-facial approach using multiple interventions have been published to date.

Objective: To develop consensus recommendations for the optimal combination and ideal sequence of botulinum toxin (BoNT), hyaluronic acid, calcium hydroxylapatite, and microfocused ultrasound with visualization (MFU-V) in persons of all Fitzpatrick skin types.

Methods and materials: Fifteen specialists convened under the guidance of a certified moderator. Consensus was defined as approval from 75% to 94% of all participants, whereas agreement of ≥95% denoted a strong consensus.

Results: Optimal aesthetic treatment of the face begins with a thorough patient assessment and an individualized treatment plan. Spacing consecutive treatments 1 to 2 weeks apart allows for resolution of side effects and/or to assess results. For same-day treatments, BoNT and fillers may be performed together in either sequence, whereas MFU-V is recommended before injectable agents.

Conclusion: Expert consensus supports a combination approach using multiple modalities in specific sequence for the safe and effective treatment of the aging face.

Publication types

  • Consensus Development Conference

MeSH terms

  • Biocompatible Materials / therapeutic use*
  • Botulinum Toxins, Type A / therapeutic use*
  • Combined Modality Therapy
  • Cosmetic Techniques*
  • Dermal Fillers / therapeutic use*
  • Durapatite / therapeutic use*
  • Esthetics*
  • Face*
  • Humans
  • Hyaluronic Acid / therapeutic use*
  • Rejuvenation
  • Skin Aging*
  • Ultrasonic Therapy / methods*
  • Viscosupplements / therapeutic use*

Substances

  • Biocompatible Materials
  • Dermal Fillers
  • Viscosupplements
  • Hyaluronic Acid
  • Durapatite
  • Botulinum Toxins, Type A